Crossmark

Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia coli or Klebsiella pneumoniae

Crossref DOI link: https://doi.org/10.1186/s13756-015-0055-6

Published Online: 2015-04-23

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Harris, Patrick N A

Yin, Mo

Jureen, Roland

Chew, Jonathan

Ali, Jaminah

Paynter, Stuart

Paterson, David L

Tambyah, Paul A
License Information

License valid from 2015-04-23
More Information

Article History

Received: 7 December 2014

Accepted: 1 April 2015

First Online: 23 April 2015